共 49 条
- [41] Five-membered 2,3-dioxo heterocycles:: LX.: Reaction of 3-aroyl-1H-pyrrolo[2,1-c][1,4]benzoxazine-1,2,4-triones with cyclic enehydrazino ketones.: Crystalline and molecular structure of N-[3′-benzoyl-4′-hydroxy-1′-(2-hydroxyphenyl)-6,6-dimethyl-2,4,5′-trioxo-1′,4,5,5′,6,7-hexahydrospiro[indole-3,2′-pyrrol]-1(2H)-yl]-3-nitrobenzamide RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2008, 44 (06) : 836 - 839
- [42] Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03): : 1122 - 1130
- [43] Synthesis of carbon-14 analogue of N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide-[carboxyl-14C] as CCK-A antagonist JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (01): : 71 - 76
- [44] Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (01): : 127 - 133
- [45] Five-membered 2,3-dioxo heterocycles: LXI. Reaction of 3-aroyl-1H-pyrrolo[2,1-c][1,4]benzoxazine-1,2,4-triones with α-enamino esters. Crystalline and molecular structure of methyl 11-benzoyl-2-o-hydroxyphenyl-3,4,10-trioxo-6,9-diphenyl-7-oxa-2,9-diazatricyclo[6.2.1.01,5]undec-5-ene-8-carboxylate Russian Journal of Organic Chemistry, 2008, 44 : 1184 - 1188
- [46] Five-membered 2,3-dioxo heterocycles:: LXI.: Reaction of 3-aroyl-1H-pyrrolo[2,1-c][1,4]benzoxazine-1,2,4-triones with α-enamino esters.: Crystalline and molecular structure of methyl 11-benzoyl-2-o-hydroxyphenyl-3,4,10-trioxo-6,9-diphenyl-7-oxa-2,9-diazatricyclo[6.2.1.01,5]undec-5-ene-8-carboxylate RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2008, 44 (08) : 1184 - 1188
- [47] SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride):: A new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01): : 414 - 424
- [48] The Discovery of N-((2H-Tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2601 - 2610
- [49] STRUCTURE AND ELECTROCHEMICAL PROPERTIES OF ANTIFERROMAGNETICALLY COUPLED BINUCLEAR HYDROXO-BRIDGED COPPER(II) COMPLEXES WITH PYRIDAZINE AND PHTHALAZINE LIGANDS - CRYSTAL AND MOLECULAR-STRUCTURES OF [MU-3,6-BIS(1-PYRAZOLYL)PYRIDAZINE-N2,MU-N3,MU-N4,N5](MU-HYDROXO)TRICHLOROAQUODICOPPER-(II)-0.8-WATER,CU2C10H11CL3N6O2.0.8H2O,[MU-3,6-BIS(1-PYRAZOLYL)PYRIDAZINE-N2,MU-N3,MU-N4,N5](MU-HYDROXO)TRIBROMOAQUODICOPPER-(II)-0.6-WATER,CU2C10H11BR3N6O2.0.6H2O, AND [MU-1,4-BIS(1-METHYL-2-IMIDAZOLYL)PHTHALAZINE](MU-HYDROXO)TRIBROMOAQUODICOPPER(II)-WATER,CU2C16H17BR3N6O3.H2OB INORGANIC CHEMISTRY, 1987, 26 (05) : 657 - 664